| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -4,269,131 | -10,282,297 | -6,261,319 |
| Depreciation | 88,588 | 21,167 | 15,241 |
| Finance lease, right-of-use asset, amortization | 14,761 | 19,731 | 69,007 |
| Unrealized gain on investments | 14,867 | 11,962 | 17,702 |
| Realized gain on investments | 107,624 | 20,327 | 20,584 |
| Amortization of debt discount | 0 | 133,700 | 367,237 |
| Change in fair value of derivative liability | 0 | -441,145 | -529,721 |
| Share-based payment arrangement, noncash expense | 1,796,774 | 6,069,560 | NaN |
| Accounts receivable, credit loss expense (reversal) | NaN | 1,064 | NaN |
| Loss on disposal | -4,603 | NaN | NaN |
| Increase (decrease) in accrued liabilities | 0 | 124,769 | 391,676 |
| Increase (decrease) in due from related parties | NaN | NaN | 137,146 |
| Other receivable | NaN | 0 | 0 |
| Increase (decrease) in accounts payable and accrued liabilities | 64,758 | -132,595 | 366,927 |
| Increase (decrease) in due to related parties | NaN | -6,833 | NaN |
| Due from shareholder | 1,526,126 | NaN | NaN |
| Increase (decrease) in deferred revenue | -14,998 | 50,000 | -245,800 |
| It represents increase decrease in grant payable | -389,000 | -175,000 | -179,967 |
| Prepaid expenses | 376,601 | -63,599 | 159,715 |
| Increase (decrease) in operating lease liability | -12,679 | -17,666 | -70,083 |
| Net cash provided by (used in) operating activities | -3,963,542 | -3,234,799 | -4,992,573 |
| Additions to long-term deposits | NaN | -104,852 | 6,050,763 |
| Purchase of property and equipment | NaN | 150,763 | NaN |
| Payments to acquire long-term investments | 0 | NaN | NaN |
| Purchase of short-term investments | 8,586,239 | 16,242,176 | 318,603 |
| Proceeds from sale of short-term investments | 10,056,100 | 2,062,019 | 301,677 |
| Net cash provided by (used in) investing activities | 1,469,861 | -14,226,068 | -6,067,689 |
| Repayment of related party notes payable | NaN | 100,000 | 0 |
| Issuance costs for convertible debentures | NaN | 0 | 0 |
| Proceeds from convertible debt | NaN | 0 | 0 |
| The amount represents proceeds from regulation financing | NaN | 7,247,931 | NaN |
| Proceeds from issuance of common stock | NaN | NaN | 7,247,931 |
| Proceeds from initial public offering | NaN | 22,061,857 | NaN |
| Proceeds from private placements | 0 | NaN | NaN |
| Cash paid for financing costs | 0 | 2,564,856 | 592,782 |
| Net cash provided by (used in) financing activities | 0 | 19,397,001 | 6,655,149 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, period increase (decrease), including exchange rate effect | -2,493,681 | 1,936,134 | -4,405,113 |
| Cash and restricted cash, end of period | 4,631,720 | 7,100,699 | 7,100,699 |
| Cash and restricted cash, end of period | 2,138,039 | 4,631,720 | 2,695,586 |
Starfighters Space, Inc. (FJET)
Starfighters Space, Inc. (FJET)